The promotion and reimbursement practices for the medtech company’s implantable CPAP alternative are under scrutiny.
CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...
Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...
Zacks Investment Research on MSN15h
INSP Stock Declines Despite Q4 Earnings Beat, Gross Margin ContractsInspire Medical Systems, Inc. INSP delivered an earnings per share (EPS) of $1.15 in fourth-quarter 2024, up 134.7% from the ...
In a highly anticipated conference call, Inspire Medical Systems reported an impressive fourth quarter and full year 2024 ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inspire Medical Systems (INSP – Research ...
Q4 2024 Earnings Call Transcript February 10, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zoetis (ZTS – Research Report), Inspire Medical Systems ...
Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback